AZ and MSD get orphan designation for neurofibromatosis drug

3rd August 2018 Uncategorised 0

Selumetinib is a MEK 1/2 inhibitor for the rare disease

More: AZ and MSD get orphan designation for neurofibromatosis drug
Source: News